替吉奥维持治疗晚期转移性乳腺癌的临床疗效及毒副反应  

The Clinical Curative Effect and Adverse Reaction of S-1 for the Treatment of Advanced Metastatic Breast Cancer

作　　者：吴晓葵[1] 穆颖 

机构地区：[1]吉林市中心医院放射线治疗科,吉林吉林132011 [2]修正药业集团长春高新制药有限公司,吉林长春130000

出　　处：《中国卫生标准管理》2014年第19期118-120,共3页China Health Standard Management

摘　　要：目的分析替吉奥维持治疗晚期转移性乳腺癌的效果及毒副反应。方法随机选取30例晚期转移性乳腺癌患者,均采取替吉奥维持治疗,分析患者的治疗效果,观察其毒副反应。结果 30例患者经替吉奥维持治疗总有效率为40%,疾病控制率为73.3%;出现8例Ⅰ-Ⅱ度骨髓抑制及5例胃肠道不适。结论替吉奥维持治疗晚期转移性乳腺癌效果显著,毒副反应轻。ObjectiveTo analyze the drug maintenance therapy in advanced and adverse reaction of metastatic breast cancer effects. Methods 30 patients with metastatic breast cancer patients with advanced, adopt S-1 maintenance therapy, treatment of patients, and observe its toxicity.Results 30 patients with S-1 maintenance treatment the total effective rate was 40%, disease control rate was 73.3%; 8 cases of Ⅰ-Ⅱ degree myelosuppression and 5 cases of gastrointestinal discomfort.Conclusion drug maintenance treatment of advanced metastatic breast cancer effect, adverse reaction.

关 键 词：替吉奥 晚期转移性乳腺癌 毒副反应 

分 类 号：R737.9[医药卫生—肿瘤]